Rare diseases
Optimize market access and care pathways for orphan drugs
Our specialized team supports healthcare players in their projects to innovate, understand and gain access to orphan drug markets.
Companies that trust us
The challenges related to rare diseases and orphan diseases
How we support you in your projects related to rare diseases or orphan diseases
What they say
-
"Together between Alcimed and Nestlé Health Science, we made informed decision on where the best opportunities were and why and how to select the most valuable assets in our investigation."
Bernard Cuenoud, Global Head of Research and Clinical Development at Nestlé Health Science
Nestlé Health Science and Alcimed mapped opportunities in the field of rare diseases with a metabolic and nutritional component, structuring a large volume of scientific data to identify and prioritize the most promising assets for development.
-
"The Alcimed teams were great for the creation of this positive atmosphere and in line with all the expectations that the Sobi teams had."
Antoine Delmotte, Immunology Complement & Speciality Care Business Unit Director at Sobi
Sobi and Alcimed co-developed the market entry strategy for a treatment targeting complement-mediated diseases, building a structured field messaging framework to prepare commercial teams for the product launch.
